P.P. Koopmans

1.3k total citations
34 papers, 986 citations indexed

About

P.P. Koopmans is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, P.P. Koopmans has authored 34 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Infectious Diseases, 15 papers in Virology and 13 papers in Epidemiology. Recurrent topics in P.P. Koopmans's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). P.P. Koopmans is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (15 papers) and Pneumocystis jirovecii pneumonia detection and treatment (10 papers). P.P. Koopmans collaborates with scholars based in Netherlands, Switzerland and Indonesia. P.P. Koopmans's co-authors include Y. A. Hekster, David M. Burger, E.W. Wuis, T. B. Vree, J.W.M. van der Meer, Patricia W. H. Hugen, C.P.W.G.M. Verwey-van Wissen, F. W. J. Gribnau, D.M. Burger and T Thien and has published in prestigious journals such as The Lancet, Analytical Biochemistry and Antimicrobial Agents and Chemotherapy.

In The Last Decade

P.P. Koopmans

34 papers receiving 941 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.P. Koopmans Netherlands 17 617 385 264 196 124 34 986
C.P.W.G.M. Verwey-van Wissen Netherlands 21 590 1.0× 347 0.9× 179 0.7× 228 1.2× 186 1.5× 34 1.1k
Robin DiFrancesco United States 18 538 0.9× 298 0.8× 137 0.5× 105 0.5× 204 1.6× 53 968
Thomas R. MacGregor United States 19 695 1.1× 487 1.3× 158 0.6× 68 0.3× 151 1.2× 46 1.3k
Belle L. Lee United States 12 438 0.7× 204 0.5× 215 0.8× 125 0.6× 142 1.1× 15 835
Charles la Porte Canada 13 478 0.8× 339 0.9× 199 0.8× 93 0.5× 99 0.8× 30 970
Robert DiCenzo United States 15 357 0.6× 195 0.5× 121 0.5× 109 0.6× 182 1.5× 25 941
John Tjia United Kingdom 17 725 1.2× 452 1.2× 177 0.7× 127 0.6× 236 1.9× 23 1.3k
John P. Sabo United States 16 555 0.9× 374 1.0× 126 0.5× 39 0.2× 134 1.1× 34 919
Sara Baldelli Italy 23 583 0.9× 132 0.3× 178 0.7× 353 1.8× 331 2.7× 67 1.3k
Patricia Lizak United States 15 296 0.5× 144 0.4× 118 0.4× 125 0.6× 107 0.9× 23 637

Countries citing papers authored by P.P. Koopmans

Since Specialization
Citations

This map shows the geographic impact of P.P. Koopmans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P. Koopmans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P. Koopmans more than expected).

Fields of papers citing papers by P.P. Koopmans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.P. Koopmans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P. Koopmans. The network helps show where P.P. Koopmans may publish in the future.

Co-authorship network of co-authors of P.P. Koopmans

This figure shows the co-authorship network connecting the top 25 collaborators of P.P. Koopmans. A scholar is included among the top collaborators of P.P. Koopmans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.P. Koopmans. P.P. Koopmans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bosch, Maurice, et al.. (2015). Validity of the Montreal Cognitive Assessment and the HIV Dementia Scale in the assessment of cognitive impairment in HIV-1 infected patients. Journal of NeuroVirology. 21(4). 383–390. 41 indexed citations
2.
Vissers, Margreet C.M., Foekje F. Stelma, & P.P. Koopmans. (2010). Could differential virological characteristics account for ongoing viral replication and insidious damage of the brain during HIV 1 infection of the central nervous system?. Journal of Clinical Virology. 49(4). 231–238. 13 indexed citations
3.
Koopmans, P.P., Ronald J. Ellis, Brookie M. Best, & Scott Letendre. (2009). Should antiretroviral therapy for HIV infection be tailored for intracerebral penetration?. PubMed. 67(6). 206–11. 15 indexed citations
4.
Koopmans, P.P., et al.. (2008). Stavudine plasma concentrations and lipoatrophy. Journal of Antimicrobial Chemotherapy. 61(4). 933–938. 10 indexed citations
5.
Kroon, Frank P., et al.. (2007). Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice. Journal of Antimicrobial Chemotherapy. 60(4). 897–900. 51 indexed citations
6.
7.
Porte, C. J. L. la, et al.. (2004). Effect of efavirenz treatment on the pharmacokinetics of nelfinavir boosted by ritonavir in healthy volunteers. British Journal of Clinical Pharmacology. 58(6). 632–640. 6 indexed citations
8.
Aarnoutse, R.E., J. A. H. Droste, Joep J. G. van Oosterhout, et al.. (2003). Pharmacokinetics, food intake requirements and tolerability of once‐daily combinations of nelfinavir and low‐dose ritonavir in healthy volunteers. British Journal of Clinical Pharmacology. 55(2). 115–125. 16 indexed citations
9.
Hugen, Patricia W. H., David M. Burger, P.P. Koopmans, et al.. (2002). Saquinavir soft-gel capsules (Fortovase) give lower exposure than expected, even after a high-fat breakfast.. Pharmacy World & Science. 24(3). 83–86. 8 indexed citations
10.
Koks, Cornelis H.W., Kristel M. L. Crommentuyn, Richard M. W. Hoetelmans, et al.. (2001). The effect of fluconazole on ritonavir and saquinavir pharmacokinetics in HIV‐1‐infected individuals. British Journal of Clinical Pharmacology. 51(6). 631–635. 19 indexed citations
11.
Burger, D.M., et al.. (2000). Determination of nevirapine, an HIV-1 non nucleoside reverse transcriptase inhibitor, in human plasma by reversed-phase high perfomance liquid chromatography. Journal of Chromatography B. 744. 64–71. 1 indexed citations
12.
Hugen, Patricia W. H., C.P.W.G.M. Verwey-van Wissen, David M. Burger, et al.. (1999). Simultaious determination of the HIV protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography.. Journal of Chromatography B. 727. 139–149. 65 indexed citations
13.
Hugen, Patricia W. H., C.P.W.G.M. Verwey-van Wissen, David M. Burger, et al.. (1999). Simultaneous determination of the HIV-protease inhibitors indinavir, nelfinavir, saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 727(1-2). 139–149. 95 indexed citations
14.
Burger, D.M., et al.. (1997). Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B. 703. 235–241. 30 indexed citations
15.
Burger, D.M., et al.. (1997). Determination of indinavir, an HIV-protease inhibitor, in human plasma by reversed-phase high-performance liquid chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 703(1-2). 235–241. 51 indexed citations
16.
Vree, T. B., et al.. (1996). Adverse reactions to co-trimoxazole in HIV infection: A reappraisal of the glutathione-hydroxylamine hypothesis. Journal of Antimicrobial Chemotherapy. 37(suppl B). 55–60. 23 indexed citations
17.
Ven, André van der, Reinout van Crevel, Gerben Bootsma, et al.. (1996). Respiratory syncytial virus pneumonia in an AIDS patient. Infection. 24(5). 375–377. 2 indexed citations
18.
Koopmans, P.P., et al.. (1992). Current status of interferon alpha in the treatment of chronic hepatitis B. Pharmacy World & Science. 14(4). 167–173. 7 indexed citations
19.
Koopmans, P.P., et al.. (1991). Adverse reactions to co-trimoxazole in HIV infection. The Lancet. 338(8764). 431–433. 118 indexed citations
20.
Koopmans, P.P., T Thien, & F. W. J. Gribnau. (1984). Influence of non-steroidal anti-inflammatory drugs on diuretic treatment of mild to moderate essential hypertension.. BMJ. 289(6457). 1492–1494. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C.P.W.G.M. Verwey-van Wissen Breakdown of academic impact, for papers by Robin DiFrancesco Breakdown of academic impact, for papers by Thomas R. MacGregor Breakdown of academic impact, for papers by Belle L. Lee Breakdown of academic impact, for papers by Charles la Porte Breakdown of academic impact, for papers by Robert DiCenzo Breakdown of academic impact, for papers by John Tjia Breakdown of academic impact, for papers by John P. Sabo Breakdown of academic impact, for papers by Sara Baldelli Breakdown of academic impact, for papers by Patricia Lizak
Rankless by CCL
2026